# Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

> **NCT03727633** · PHASE2 · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 44 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** Idarubicin and Lipiodol

## Key facts

- **NCT ID:** NCT03727633
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-19
- **Primary completion:** 2025-06-18
- **Final completion:** 2026-01-03
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Enrollement rythm low, funding body decision.
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727633, "Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03727633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*